Mojgan Devouassoux‐Shisheboran

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Nicoletta Colombo, Cristiana Sessa, Andreas du Bois et al. · Annals of Oncology · 2019 · 1.1K citations · Full text

Borderline Tumours, Tumoral Pathology, Medicine +9

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

François Le Loarer, Sarah Watson, Gaëlle Pierron et al. · Nature Genetics · 2015 · 350 citations

Malignant Disease, Medicine, Cancer Cell Biology +11

A Clinicopathologic Study of 100 Cases of Pulmonary Sclerosing Hemangioma With Immunohistochemical Studies

Mojgan Devouassoux‐Shisheboran, Tomayoshi Hayashi, R. Ilona Linnoila et al. · The American Journal of Surgical Pathology · 2000 · 347 citations

Immunohistochemical Studies, Clinicopathologic Study, Multiple Pulmonary Nodule +13

Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non–Small-Cell Lung Cancer

M. Pérol, C. Chouaïd, David Pérol et al. · Journal of Clinical Oncology · 2012 · 232 citations

Mesonephric Adenocarcinomas of the Uterine Cervix

Susan A. Silver, Mojgan Devouassoux‐Shisheboran, Thomas Mezzetti et al. · The American Journal of Surgical Pathology · 2001 · 214 citations

Mesonephric Adenocarcinoma, Tumoral Pathology, Cervical Cancer +12